Berlin, Germany
February 9, 2002
The goals of the symposium "Is aging a disease?" were:
- to explain the biological, endocrinological and metabolic aspects of aging and its clinical consequences;
- to discuss the management of the growth hormone decline associated with aging in the perspective of a review of clinical trials undertaken with the use of GH, GHRH, Secretagogues and IGF-1;
- to discuss the diagnostic aspects of aging and to propose therapeutic guidelines for GH replacement.
OBJECTIVES
At the conclusion of this program, the participant was able to:
- Describe the biology, the endocrine system and metabolic changes associated with aging.
- Review the clinical aspects of aging and to understand the clinical consequences of aging.
- Understand the rationale for GH replacement in aging and to explain current research and clinical investigations related mainly to the use of GH, GHRH (together with secretagogues and IGF-1) in aging.
- Review the diagnostic aspects of aging, the indications and contraindications to GH replacement in aging and to propose therapy guidelines for GH replacement therapy in aging.
Serono Symposia USA, Inc., is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians.
Serono Symposia USA, Inc., designates this education activity for a maximum of 1.5 credit hours in category I credit towards the AMA Physician’s Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the educational activity.
CME accreditation for this program has been applied for from the Royal College of Physicians, London, UK.
